ArticleOncotarget2017

Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, STAT3 and ERK signaling.

Jingkai Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.